Wayne Ray

There is strong evidence that the medication apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stoke prevention in patients with atrial fibrillation (AF), with both reduced rates of severe bleeding complications as well as strokes, according to study published Dec. 21 in JAMA. Read More

The findings reinforce guidelines for cautious use of antipsychotics in younger populations, according to senior author Wayne Ray. Read More

The Vanderbilt University School of Medicine Master of Public Health (MPH) Program marked its 20th anniversary during Reunion Weekend in October. Read More

A Vanderbilt University study published today in the Journal of Clinical Psychiatry may help patients prescribed higher doses of certain antidepressants feel better about attributed cardiac risks. Read More

Long-acting opioids are associated with a significantly increased risk of death when compared with alternative medications for moderate-to-severe chronic pain, according to a Vanderbilt study released today in the Journal of the American Medical Assocation (JAMA). Read More

With a greater focus on how the health care system functions, particularly in the wake of the 2009 Affordable Care Act, Vanderbilt has adjusted its own research and teaching programs surrounding public health and health policy. Read More

The 2015 Vanderbilt University Medical Center Academic Enterprise Faculty Awards, which were presented during the May 19 Spring Faculty meeting, included awards for Excellence in Teaching and Outstanding Contributions to Research. Read More

Outside the hospital, use of methadone to treat pain carries a 46 percent increased risk of death when compared to the equally effective but more costly alternative, morphine SR (sustained release). Read More

Prescribing “atypical” antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows. Read More

The U.S. Food and Drug Administration is investigating the antibiotic azithromycin after a Vanderbilt study shed light on a rare but important risk. Read More

Vanderbilt researchers have discovered a rare, but important risk posed by the antibiotic azithromycin, commonly called a “Z-pack.” The study found a 2.5-fold higher risk of death from cardiac arrhythmia in the first five days of taking azithromycin when compared with another common antibiotic or no antibiotics at all. Read More

After a storied history of achievement in the areas of teaching, research and advocacy in the fields of prevention and public health, Vanderbilt’s Department of Preventive Medicine is expanding and will be re-named. Read More